NEXTCURE, INC Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
NEXTCURE, INC (NXTC) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $0 as of 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2022-03-03
- 2021-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2021-03-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2020-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-03 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2019-03-31 | $0.00 10-Q · filed 2020-08-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |